LLY compared with CATX: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

CATXPerspective Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

CATXPerspective Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

Q1 FY26±5.3%▲+9.80%×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

CATX

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±21.1%▲+6.00%×0.28

May 12 '26±85.0%▼−2.84%×0.03

= impliedLLY realized, solidCATX realized, hatchedOne scale, both sides: full bar = 88%× = |realized| ÷ impliedSource: market data

Q1 FY26

±10.4%

▼−5.17%

×0.50

Jan 9 '26±87.1%▲+1.07%×0.01

LLYELI Lilly & Co

1,364.95▲+0.02%

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

CATXPerspective Therapeutics, Inc.

0.84▲+6.49%

Regular sessionNov 6 '26

Mkt cap$90.0MRevenue$81,000Q2 FY26Revenue$884,000FY25

Compare

Regular sessionNov 6 '26

LLYELI Lilly & Co

CATXPerspective Therapeutics, Inc.

1,364.95▲+0.02%

Price

0.84▲+6.49%

$1.2T

Mkt cap

$90.0M

Q3 FY26$24.4B

Revenue

$81,000Q2 FY26

FY25$65.2B

Revenue

$884,000FY25

LLY1,364.95▲+0.02%vsCATX0.84▲+6.49%Regular sessionNov 6 '26